Unyvero P55 application

SKU:P55

Pneumonia is an acute infection of the respiratory tract with high incidence and, in hospitalized patients, is usually caused by bacteria. 5% of hospitalized patients develop this rapidly advancing condition with mortality rates of up to over 30% and an average hospital stay of 11 to 14 days.

Current standard diagnostics use microbiological cultures to detect bacteria and their antibiotic resistances. However, this method means that the results are only available after one to five days. Due to the lack of diagnostic results, most cases of pneumonia are treated empirically. This results in a high rate (~40%) of initially inadequate antibiotic treatments. Studies have shown that early targeted antibiotic treatment can significantly reduce both the mortality rate and the length of the hospital stay.

The Unyvero Pneumonia Application was developed to improve diagnosis of pathogens and the resistance of these pathogens in acute bacterial pneumonia. This application

enables sputa, respiratory aspirates and bronchial lavages to be tested
combines all analytical steps into one complete test format, thereby reducing the test process to a few simple manual steps
detects various microorganisms and antibiotic resistance markers in native patient samples simultaneously within approx. four hours

9 RESISTANCE MARKERS ? 20 PATHOGENS
The Unyvero P55 Pneumonia Cartridge

This cartridge enables the detection of a total of 39 analytes and combines the following functions:

-DNA purification
-PCR set up
-8 parallel multiplex endpoint PCRs
-Amplicon detection by array hybridization COVERS ALL CLINICALLY RELEVANT PATHOGENS AND RESISTANCES
The Unyvero Pneumonia Panel

Developed in cooperation with European and US KOLs.

The panel was primarily developed to include patients with the following risks:

-pathogens that cause serious and difficult-to-treat types of pneumonia (such as Pseudomonas aeruginosa)
-pathogens that carry antimicrobial substances in them and make isolation necessary
-infections with multidrug resistant bacteria (MDR) that are not covered by empirical treatment regimes
The Unyvero Pneumonia Panel covers relevant antibiotic resistances that can occur in the case of pneumonia by analyzing 39 genetic markers:

-ß-lactam resistance, including ESBL
-kpc resistance
-Macrolide resistance
-Fluoroquinolones resistance
-Multidrug resistance (MDR)

EXPRESSION OF INTEREST FORM

PRODUCT

SKU

NAME

SURNAME

EMAIL

TELEPHONE

MESSAGE

Contact me via

Helix_logoDetailBlueRELATED PRODUCTS